Real-world use of ruxolitinib in patients with myelofibrosis with anemia or thrombocytopenia VJHemOnc – Video Journal of Hematology & HemOnc 2:07 1 year ago 460 Далее Скачать
Momelotinib vs Ruxolitinib in JAKi-naive Patients With Myelofibrosis Cancer Therapy Advisor 1:25 7 years ago 134 Далее Скачать
Efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from MOMENTUM VJHemOnc – Video Journal of Hematology & HemOnc 3:48 2 years ago 318 Далее Скачать
Phase 3 Trial of Momelotinib Versus Ruxolitinib in JAK Inhibitor Naive Patients with Myelofibrosis MPNUniversity .tv 4:20 7 years ago 159 Далее Скачать
Safety and anemia outcomes with momelotinib vs pacritinib in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:20 1 year ago 328 Далее Скачать
Phase 3 Trial of Momelotinib Versus Ruxolitinib in JAK Inhibitor Naive Patients with Myelofibrosis Oncology.TV 4:20 7 years ago 380 Далее Скачать
Approved and emerging agents to manage anemia and thrombocytopenia in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:49 1 year ago 276 Далее Скачать
PACIFICA: Phase III study of pacritinib vs BAT in patients with MF and severe thrombocytopenia VJHemOnc – Video Journal of Hematology & HemOnc 1:21 1 year ago 217 Далее Скачать
Pacritinib versus ruxolitinib in patients with myelofibrosis and thrombocytopenia VJHemOnc – Video Journal of Hematology & HemOnc 1:59 2 years ago 332 Далее Скачать
Momelotinib: a promising drug for patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:43 2 years ago 850 Далее Скачать
Analysis of long-term exposure to momelotinib in the Phase III SIMPLFY myelofibrosis trials VJHemOnc – Video Journal of Hematology & HemOnc 2:07 4 years ago 113 Далее Скачать
Recent updates from the MOMENTUM trial and the value of momelotinib for the treatment of MF VJHemOnc – Video Journal of Hematology & HemOnc 1:53 2 years ago 119 Далее Скачать
FDA Approves JAK Inhibitor Momelotinib for Myelofibrosis in Anemic Adults Medical Dialogues 2:25 1 year ago 235 Далее Скачать
Indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:16 1 year ago 113 Далее Скачать
The use of pacritinib in thrombocytopenic patients with myelofibrosis undergoing alloSCT VJHemOnc – Video Journal of Hematology & HemOnc 1:17 1 year ago 129 Далее Скачать
Momelotinib for the treatment of myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:40 4 years ago 217 Далее Скачать
Design and results of pacritinib for myelofibrosis trial (PERSIST-1) VJHemOnc – Video Journal of Hematology & HemOnc 1:45 9 years ago 71 Далее Скачать
Inadequate or Loss of Response to Ruxolitinib and Combination Strategies in Myelofibrosis HMP Education 22:08 9 years ago 894 Далее Скачать
Ruben Mesa, MD: Momelotinib Non-Inferior to Ruxolitinib in Myelofibrosis American Society of Hematology 5:33 7 years ago 751 Далее Скачать
MOMENTUM: momelotinib vs danazol in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:12 3 years ago 982 Далее Скачать
